SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK
The grant will support clinical trials of rare disease therapy for leukodystrophy
Read More
Author: PharmaTimes
AMR testing technology from QuantaMatrix backed by research paper in Nature
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
Read More
GOSH and Oliver Patch in cancer research partnership with Innovative Trials
Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma
Read More
Theramex’s Eladynos recommended by NICE for post-menopausal bone disease
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause
Read More
eXmoor pharma’s manufacturing facility receives licence from MHRA
The company’s Cell & Gene Therapy Centre can now offer a full range of GMP services
Read More- HSE approves new treatment for hidradenitis suppurativa and axial spondyloarthritis
- MSD to acquire Cidara after positive phase 2b trial results
- eXmoor Pharma and Royal Free London link to strengthen UK gene therapy
- Alzheimer’s prevention charity pioneers research on nutrition biomarkers to detect risk
- NICE recommends vutrisiran for adults with ATTR-CM in final draft guidance
